Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

SVA

Sernova (SVA)

Sernova Corp
から:
次の項目別のソート:
 Showing the most relevant articles for your search:TSXV:SVA
日付受信時刻ニュースソース見出しコード企業名
2022/06/0300 : 00PR Newswire (Canada)Sernova Opens the MarketTSXV:SVASernova Corp
2022/01/1023 : 48PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
2022/01/1023 : 46PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
2022/01/1023 : 44PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
2022/01/1023 : 41PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
2021/02/0500 : 01PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
2021/02/0423 : 58PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
2021/02/0423 : 44PR Newswire (Canada)Sernova Upsizes Previously Announced Bought Deal Public Offering to C$20 MillionTSXV:SVASernova Corp
2021/02/0423 : 38PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
2021/02/0423 : 36PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
2021/02/0407 : 20PR Newswire (Canada)Sernova Corp. Announces C$10 Million Bought Deal Offering of UnitsTSXV:SVASernova Corp
2021/01/1604 : 48PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
2021/01/1604 : 45PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
2021/01/1604 : 30PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
2021/01/1604 : 27PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
2020/06/1901 : 58InvestorsHub NewsWirePURA SVA - Health Stocks Exhibit Healthy News, Robust Share HikesTSXV:SVASernova Corp
2019/10/2420 : 30PR Newswire (Canada)Sernova Announces Biotech Veteran as New Chief Financial OfficerTSXV:SVASernova Corp
2019/10/1701 : 55InvestorsHub NewsWireSernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-ATSXV:SVASernova Corp
2019/04/1201 : 14InvestorsHub NewsWireSernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical StudyTSXV:SVASernova Corp
2018/07/0523 : 50InvestorsHub NewsWireSernova Initiates Patient Screening and Recruitment for its US Clinical Trial for DiabetesTSXV:SVASernova Corp
2018/02/2222 : 35InvestorsHub NewsWireSernova's Cell Pouch Regenerative Medicine Clinical Trial for Type 1 Diabetes Supported with CGM SystemsTSXV:SVASernova Corp
2017/12/1123 : 03PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
2017/12/1123 : 02PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
2017/12/1121 : 56InvestorsHub NewsWireSernova Receives US FDA IND Allowance to Initiate a US Clinical Trial of its Cell Pouch for the Treatment of Type 1 DiabetesTSXV:SVASernova Corp
2017/12/0904 : 20PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
2017/12/0904 : 19PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
2014/07/1519 : 00Marketwired CanadaSernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology For the Treatment of DiabetesTSXV:SVASernova Corp
2014/06/2419 : 00MarketwiredSernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San DiegoTSXV:SVASernova Corp
2014/06/2419 : 00Marketwired CanadaSernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San DiegoTSXV:SVASernova Corp
2014/06/2019 : 00MarketwiredSernova's CEO Dr. Philip Toleikis Featured on BNNTSXV:SVASernova Corp
 Showing the most relevant articles for your search:TSXV:SVA

最近閲覧した銘柄